Y. Takai

发表

Lipid structure of cytotoxic granules in living human killer T lymphocytes studied by Raman microspectroscopy.

H. Takeuchi, Y. Takai, T. Masuko, 1997, Biochimica et biophysica acta.

IL-4-supported induction of cytolytic T lymphocytes requires IL-2 and IL-6.

M. Bertagnolli, S. Herrmann, Y. Takai, 1991, Cellular immunology.

Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.

H. Fujiwara, J. Shimizu, T. Hamaoka, 1986, Journal of immunology.

Application of T Cell—T Cell Interaction to Enhanced Tumor-Specific Immunity Capable of Eradicating Tumor Cells in Vivo

H. Fujiwara, T. Hamaoka, T. Suda, 1987 .

Enhanced production of IL-6 in tumor-bearing mice and determination of cells responsible for its augmented production.

H. Fujiwara, T. Hamaoka, Y. Takai, 1990, Journal of immunology.

The augmentation of tumor-specific immunity by virus help

M. Fukuzawa, H. Fujiwara, T. Hamaoka, 1986, Cancer Immunology, Immunotherapy.

Requirements of adherent cells for activating Lyt-1+2- T cells as well as for functioning as antitumor effectors activated by factor(s) from Lyt-1+2- T cells.

H. Fujiwara, T. Hamaoka, Y. Takai, 1986, Japanese journal of cancer research : Gann.

Requirement for three distinct lymphokines for the induction of cytotoxic T lymphocytes from thymocytes.

S. Herrmann, S. Burakoff, J. Greenstein, 1986, Journal of immunology.

B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes.

S. Clark, S. Herrmann, S. Burakoff, 1988, Journal of immunology.

Constitutive Expression of Interleukin‐7 mRNA and Production of IL‐7 by a Cloned Murine Thymic Stromal Cell Line

S. Nishikawa, H. Fujiwara, Y. Tsuruta, 1990, Journal of leukocyte biology.

The augmentation of tumor-specific immunity using haptenic muramyl dipeptide (MDP) derivatives

H. Fujiwara, T. Kusama, T. Hamaoka, 2004, Cancer Immunology, Immunotherapy.

Direct evidence for a receptor-ligand interaction between the T-cell surface antigen CD2 and lymphocyte-function-associated antigen 3.

M. Reed, S. Herrmann, S. Burakoff, 1987, Proceedings of the National Academy of Sciences of the United States of America.

The augmentation of tumor‐specific immunity by virus help. I. Demonstration of vaccinia virus‐reactive helper T cell activity involved in enhanced induction of cytotoxic T lymphocyte and antibody responses

H. Fujiwara, T. Hamaoka, Y. Takai, 1984, European journal of immunology.

Enhanced production of interleukin-6 in mice with type II collagen-induced arthritis.

F. Lee, H. Fujiwara, T. Hamaoka, 1989, Arthritis and rheumatism.

The role of tumor-specific Lyt-1+2− T cells in eradicating tumor cells in vivo

H. Fujiwara, J. Shimizu, T. Hamaoka, 1987, Cancer Immunology, Immunotherapy.

The augmentation of tumor-specific immunity by virus help. III. Enhanced generation of tumor-specific Lyt-1+2- T cells is responsible for augmented tumor immunity in vivo.

M. Fukuzawa, H. Fujiwara, T. Hamaoka, 1986, Cancer immunology, immunotherapy : CII.

T-T cell interaction in the induction of delayed-type hypersensitivity (DTH) responses: vaccinia virus-reactive helper T cell activity involved in enhanced in vivo induction of DTH responses and its application to augmentation of tumor-specific DTH responses.

H. Fujiwara, T. Hamaoka, A. Kosugi, 1985, Journal of immunology.

The mechanism of tumor growth inhibition by tumor-specific Lyt-1+2-T cells. I. Antitumor effect of Lyt-1+2-T cells depends on the existence of adherent cells.

H. Fujiwara, T. Hamaoka, Y. Takai, 1985, Journal of immunology.

Capacities of a Newly Established Thymic Stromal Cell Clone to Express la Antigens and to Produce Interleukin‐6, Colony‐Stimulating Factor, and Thymic Stroma‐Derived T‐Cell Growth Factor

H. Fujiwara, T. Katagiri, K. Ishimura, 1989, Journal of leukocyte biology.

Modelforclonal elimination inthethymus (thymic selection/self-tolerance/clonal deletion/thymic stroma-derived T-cell growth factor)

S. Maruo, Y. Takai, I. Hikita, 1989 .

Proliferation and differentiation of immature thymocytes induced by a thymic stromal cell clone.

H. Fujiwara, T. Hamaoka, Y. Takai, 1990, Thymus.

Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.

H. Fujiwara, T. Hamaoka, T. Tsuchida, 1985, Journal of immunology.

Identification of IL-7-dependent bone marrow-derived Thy-1-B220- lymphoid cell clones that rearrange and express both Ig and T cell receptor genes.

Y. Kita, X. Tai, T. Hamaoka, 1992, Journal of immunology.

Not Only Hypoxia- but Radiation-Induced Epithelial-Mesenchymal Transition Is Modulated by Hypoxia-Inducible Factor 1 in A549 Lung Cancer Cells.

K. Hirose, Y. Hatayama, H. Kawaguchi, 2021, Folia biologica.